Valby, Denmark, 2016-05-11 07:42 CEST (GLOBE NEWSWIRE) -- HIGHLIGHTS Revenue reached DKK 3,770 million in the first quarter of 2016 representing an increase of 6% both reported and in local currencies compared to the same period last year Total revenue have delivered a better performance than

Valby, Denmark, 2017-05-10 07:43 CEST (GLOBE NEWSWIRE) -- HIGHLIGHTS Revenue reached DKK 4,211 million in the first quarter of 2017 representing an increase of 12% compared to the same period last year Revenue in North America increased by 21% to DKK 2,437 million (21% in local currency) Revenue in

H. Lundbeck A/S (Lundbeck) strengthens its pipeline of pharmaceuticals in clinical development by initiating clinical phase I studies with Lu AF11167 in order to investigate safety, tolerability and the pharmacokinetic profile of the drug in humans. Lu AF11167 is a new compound inhibiting a

Den første FDA-godkendte månedlige, langtidsvirkende, injicerbare behandling til vedligeholdelsesbehandling af bipolar I lidelse I hos voksne 1,2 Den nye indikation for Abilify Maintena er baseret på et forsøg, der evaluerer præparatets effekt og sikkerhed til behandling af voksne patienter med

First FDA-approved, once-monthly, long-acting injectable for the maintenance monotherapy treatment of bipolar I disorder in adults 1,2 New indication for Abilify Maintena is based on studies evaluating efficacy and safety in adult patients with bipolar I disorder 1 Valby, Denmark and Tokyo, Japan,

H. Lundbeck A/S hereby reports transactions made by executives and persons and legal entities closely associated to them with shares in H. Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act. The list is based on reports received by H.

H. Lundbeck A/S hereby reports transactions made by executives and persons and legal entities closely associated to them with shares in H. Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act. The list is based on reports received by H.

H. Lundbeck A/S hereby reports transactions made by executives and persons and legal entities closely associated to them with shares in H. Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act. The list is based on reports received by H.

H. Lundbeck A/S hereby reports transactions made by executives and persons and legal entities closely associated to them with shares in H. Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act. The list is based on reports received by H.

H.  Lundbeck A/S hereby reports transactions  made by executives and persons and legal  entities closely associated  to them with  shares in H.  Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act. The  list is  based on  reports received  by H.  Lundbeck A/S